Gordon Campbell | Parliament TV | Parliament Today | News Video | Crime | Employers | Housing | Immigration | Legal | Local Govt. | Maori | Welfare | Unions | Youth | Search


Hear the voice of those with rare disorders

Hear the voice of those with rare disorders

Rare disease patients and their support groups are calling on the government to put in place an orphan drugs access programme, similar to those in place or being developed in most other OECD countries.

They say that Pharmac is unable to manage access to specialised medicines under its current framework, and are calling for separate management of these medicines in the Ministry of Health, just like the separate process in place now for very specialised and high cost medical and surgical treatments.

The omission of fairness and equity from Pharmac’s policy and decisions relating to specialised medicines is regarded by the groups as a serious conflict with the rights of the patients and at variance with health legislation, health strategies, and Ministry of Health guidelines for decision making, which all place equity, fairness and community values into decision criteria.

NZORD and the support groups endorse Pharmac’s core role of getting a good deal on medicines for the bulk of the population, but say that Pharmac’s track record regarding medicines for orphan diseases is an appalling failure. “We think they should be left to get on doing what they can do well, and have their failure remedied by removing it from their responsibility,” the groups say.

Thursday 28 February is Rare Disease Day and draws attention to the needs of those with rare disorders. NZORD, the NZ Organisation for Rare Disorders, is hosting a seminar today at which several patients will be talking about their difficulties getting access to new treatments for rare “orphan” diseases. The groups’ concerns are reinforced by presentations from health researcher Greg Coyle who will discuss the findings of his PhD thesis which examined Pharmac’s exceptional circumstances scheme, and lawyer Lucy Elwood will be discussing legal aspects of the issues.

John Forman, executive director of NZORD says “These patients are being abandoned by the health system. There is a systems failure in this area, as the moral factors of fairness, equity and community values are not being included in Pharmac’s decisions on specialised medicines.”

“The 2011 review of the exceptional circumstances scheme and the introduction of the new NPPA scheme, actually made it more difficult for rare disease patients to get a fair hearing,” says Forman. “The criteria changed so rarity was no longer a prerequisite, but they also made it practically an exclusion criteria”, he said.

The criteria reflect Pharmac’s narrow health economics and budget management approach, and exclude the very important moral factors of equity, fairness, and community values. It appears to be a deliberate exclusion of moral considerations from decision making.

In trying to find solutions and answers to the way in which access to “orphan” medicines is managed, NZORD and a number of associated support groups have been sent around in circles. After a test case under the new system, which was rejected by Pharmac as not eligible for consideration, they approached Ministers for an examination of the policy framework, but were ‘fobbed off’. They then approached the Health Select Committee who directed them to the Health Minister. The Minister initiated a report from the Ministry of Health into the groups’ concerns, but before briefing with the Ministry were even completed the Minister wrote to say he could not interfere with funding decisions by Pharmac, despite the request being about policy accountability, not a specific funding decision. The Minister then referred the matter to Pharmac which resulted in a bland avoidance letter from Pharmac.

Unable to get any traction from these approaches, the groups submitted a case to the Ombudsman in October 2012, claiming unfair application of the policy to an individual case, and suggesting that the policy itself was not fairly formed. The case is still being investigated by the Ombudsman and a response is expected soon.

Groups participating in today’s seminar include:
The Muscular Dystrophy Association of New Zealand www.mda.org.nz
Lysosomal Diseases New Zealand www.ldnz.org.nz
The PNH Support Association of New Zealand www.pnhsanz.org.nz
Hereditary Angioedema Australasia www.haeaustralia.org.au


© Scoop Media

Parliament Headlines | Politics Headlines | Regional Headlines



1080 Threat: Police Arrest 60 Year Old Auckland Man

New Zealand Police have arrested a 60-year-old Auckland businessman in relation to the criminal blackmail threat to poison infant formula with 1080, made public in March this year. More>>


Canterbury Transition Bill First Reading: Government Hiding From ECan Submissions

The Government has radically reduced the amount of time for public submissions on their controversial ECan bill, says Labour’s Environment spokesperson Megan Woods... “Their shortened timeline could mean that instead of the usual six weeks, Cantabrians get just one week to submit their views on the bill." More>>


Gordon Campbell: On Our Apparent Inability To Stand Up To Australia

Alas, and only days before the first meeting between our Prime Minister John Key and the new Australian leader Malcolm Turnbull, this country is showing no sign of standing up for itself. Quite the reverse. We seem to be rolling over, and making gestures of appeasement. More>>


Health Not-So-Many Benefits: Auditor-General On Scrapped Cost-Saving Plan

The Auditor-General decided to look into the costs and benefits of HBL’s work in the health sector and, where possible, identify lessons... We found that several factors contributed to the difficulties that befell HBL and, in particular, the Finance, Procurement and Supply Chain (FPSC) programme. More>>


Wikileaks: TPP Intellectual Property Rights Chapter Released

“If TPP is ratified, people in the Pacific-Rim countries would have to live by the rules in this leaked text,” said Peter Maybarduk, Public Citizen’s Global Access to Medicines Program Director. “The new monopoly rights for big pharmaceutical firms would compromise access to medicines in TPP countries. The TPP would cost lives.” More>>


Redundancies: 120 Laws To Be Repealed

The Statutes Repeal Bill will remove 120 pieces of superfluous legislation, and parts of eight other acts. It is being consulted on before it is introduced to Parliament. “The proposed Bill would reduce the total number of public Acts in force by more than 10%,” Mr Joyce says. More>>


Gordon Campbell: On John Key’s Trip To Iraq

In the embedded press coverage on this trip, the absence so far of any evaluation of the wider context of what New Zealand thinks it is doing at Camp Taji has been striking. More>>


Labour: Parata Puts Brakes On Charter School Appraisal

“When the Ministry of Education recommended they compare the achievements of children at charter schools to those of their counterparts at state schools, the documents show Hekia Parata specifically prohibited them from doing so." More>>


Bad Day For Universities: Gun, Bomb Threats On Three Campuses

Dunedin Police are continuing their investigation into the threat made against the University of Otago. Staff are following a number of lines of inquiry, and police are working to verify the authenticity and source of the post. More>>


Get More From Scoop



Search Scoop  
Powered by Vodafone
NZ independent news